Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

Similar articles for PubMed (Select 22288962)

1.

Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):155-62. doi: 10.5858/arpa.2011-0232-OA.

PMID:
22288962
2.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
3.
4.

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.

Brown AF, Sirohi D, Fukuoka J, Cagle PT, Policarpio-Nicolas M, Tacha D, Jagirdar J.

Arch Pathol Lab Med. 2013 Sep;137(9):1274-81. doi: 10.5858/arpa.2012-0635-OA. Epub 2013 Jan 4.

PMID:
23289761
5.

Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.

Warth A, Muley T, Herpel E, Meister M, Herth FJ, Schirmacher P, Weichert W, Hoffmann H, Schnabel PA.

Histopathology. 2012 Dec;61(6):1017-25. doi: 10.1111/j.1365-2559.2012.04308.x. Epub 2012 Aug 8.

PMID:
22882703
6.

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.

J Thorac Oncol. 2010 Apr;5(4):436-41. doi: 10.1097/JTO.0b013e3181c6ed9b.

PMID:
20068475
7.

Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma.

Iqbal J.

Arch Pathol Lab Med. 2013 Feb;137(2):155. doi: 10.5858/arpa.2012-0123-LE. No abstract available.

PMID:
23368855
8.

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.

Bishop JA, Sharma R, Illei PB.

Hum Pathol. 2010 Jan;41(1):20-5. doi: 10.1016/j.humpath.2009.06.014. Epub 2009 Sep 8.

PMID:
19740516
9.

Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.

Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H.

Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):313-7. doi: 10.1097/PAI.0b013e318205b059.

PMID:
21464700
10.
11.

Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.

Johnson H, Cohen C, Fatima N, Duncan D, Siddiqui MT.

Acta Cytol. 2012;56(6):596-602. doi: 10.1159/000339793. Epub 2012 Nov 24.

PMID:
23207437
12.

Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.

Brunnström H, Johansson L, Jirström K, Jönsson M, Jönsson P, Planck M.

Am J Clin Pathol. 2013 Jul;140(1):37-46. doi: 10.1309/AJCP50RDXSCSBTBO.

13.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

14.

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.

Sethi S, Geng L, Shidham VB, Archuletta P, Bandyophadhyay S, Feng J, Madan S, Shi D, Tranchida P, Giorgadze T.

Cytojournal. 2012;9:10. doi: 10.4103/1742-6413.94570. Epub 2012 Mar 31.

15.

TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.

Fatima N, Cohen C, Lawson D, Siddiqui MT.

Cancer Cytopathol. 2011 Apr 25;119(2):127-33. doi: 10.1002/cncy.20135. Epub 2011 Feb 1.

PMID:
21287692
16.
17.

Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.

Liu L, Cohen C, Siddiqui MT.

Acta Cytol. 2012;56(4):425-30. doi: 10.1159/000337439. Epub 2012 Jul 25.

PMID:
22846220
18.

The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.

Roh MH, Schmidt L, Placido J, Farmen S, Fields KL, Courey AJ, Arenberg DA, Knoepp SM.

Diagn Cytopathol. 2012 Nov;40(11):949-55. doi: 10.1002/dc.21680. Epub 2011 Apr 15.

PMID:
21500373
19.

Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.

Yanagita E, Imagawa N, Ohbayashi C, Itoh T.

Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):509-13. doi: 10.1097/PAI.0b013e318212f027.

PMID:
21415705
20.

Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.

Wu M, Szporn AH, Zhang D, Wasserman P, Gan L, Miller L, Burstein DE.

Diagn Cytopathol. 2005 Oct;33(4):223-7.

PMID:
16138374
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk